Mergers & Acquisitions
Biotechnology - The Pharmaceutical Market: Israel. Enhanced Strategic Intelligence In A User-Friendly Format
2012 JUN 27 (VerticalNews) -- By a News Reporter-Staff News Editor at Mergers & Acquisitions Business -- Research and Markets (http://www.researchandmarkets.com/research/zzphmc/the_pharmaceutical) has announced the addition of the "The Pharmaceutical Market: Israel" report to their offering. The Reports Provide: - Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators ...read more
Biotechnology - Spectrum Pharmaceuticals to Be Added to the S&P SmallCap 600 Index
2012 MAY 2 - (VerticalNews.com) -- Spectrum Pharmaceuticals (Nasdaq: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced that the company has been selected to be added to the S&P SmallCap 600® Index at the close of trading on Tuesday, April 24, 2012. Following this addition, the Company will be a component of the NASDAQ Biotechnology Index®, the Russell 3000®, Russell 2000®, Russell Global® and S&P SmallCap 600® indices ...read more
Biotechnology - ICON Acquires PriceSpective
2012 MAR 14 - (VerticalNews.com) -- ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced the acquisition of PriceSpective LLC, a global leader in value strategy consulting. The acquisition strengthens ICON's expertise in value based pricing and market access, and together with the health economics and patient reported outcomes services acquired through Oxford Outcomes, enables ICON to offer the industry's most integrated regulatory, clinical and market access solution ...read more
View more articles on Biotechnology.